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INTRODUCTION 
Obesity and Diabetes     
    Recent statistics show that obesity (BMI over 30kg/m2) has become one of the most serious 
global health problems (1). The situation is even worse in America, where more than 30 percent 
of the adult population is obese, and the trend is alarming (2). Since obesity is considered to be a 
key risk factor in various conditions, such as cardiovascular diseases, hypertension, arthritis and 
diabetes, more researchers are investigating means to prevent and treat obesity (3). 
Diabetes is also a severe disease which threatens people’s heath. Statistics from the World 
Health Organization showed that the global prevalence has reached up to 10%, the number is 
even higher in some specific areas (4). The origin of diabetes can be many different factors such 
as genetic, environmental factors that related to diet, life-style, and lack of exercise, and 
intestinal microbiota condition. Researchers also have reported that the inflammatory stress may 
lead to insulin resistance (5).  
Probiotics and Prebiotics 
Scientists are putting more and more attentions on probiotics for obesity treatment and 
diabetes prevention in recent years due to the incredible benefits displayed by probiotics. 
Probiotics are live microorganisms which can provide a health benefit for the host when its 
amount is sufficient (6). Particularly, some probiotics have the ability to alter the gut microbiota 
for regulating inflammatory which can reduce potential insulin resistance caused by the stress of 
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inflammatory. And some probiotics have the ability to contribute to host strain and improve the 
metabolism system in human body. In another word, there are different health benefits, which 
mainly depend on the specific strain and specific amount (7). Therefore, gut microbiome could 
largely affect a person’s health status (8).    
 The probiotics of interest for our study is Christensenella minuta (C. minuta), C. minuta 
was first found in the human gut as a Gram-negative, strictly anaerobic bacterium (9). A recent 
study related to gut microbiome has shown that C. minuta reduced body weight gain in the 
recipient mice (10), suggesting that C. minuta as a gut microbiota may provide potential benefits 
related to obesity treatment by modulating the host microbiome system (11). 
Prebiotics are non-digestible carbohydrates that can be selectively fermented by the gut 
bacteria. The process could have a beneficial effect on metabolism and gut health (12). Several 
recent researches have reported that prebiotics have the ability to alter the gut microbiota (13). 
Furthermore, current diet, especially western-type diet, contains limited amount of prebiotics 
(14). Prebiotics were also investigated and applied during our study for promoting the growth of 
growth of C. Minuta. Galactooligosaccharides (GOS) was added during C. Minuta microsphere-
making process due to its stability in acidic conditions and specific promotion of these probiotics 
(15). 
Encapsulation 
The ability of probiotics to survive during storage (in food products) and gastrointestinal 
digestion is extremely important for them to exert any beneficial activities. The gastrointestinal 
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tract, which is the first physiological step of digesting and absorbing nutrients from diet, will kill 
most of probiotics due to the harsh acidic condition (16). Moreover, it is indicated that food 
containing probiotic bacteria once consumed by humans should contain at least 109 live 
microorganisms per g or mL in order to exert its protective effects as recommended (17). As we 
mentioned before, the probiotic that we are focusing on is anaerobic and has a low survive-rate 
after GIT. Therefore, a way to protect the probiotic from being killed and maintaining its 
viability during the storage and GI digestion is needed.  
Encapsulation techniques are considered to be one of the most effective techniques to help 
bacteria go through GIT without significant loss in cell viability and prevent possible interaction 
during the storage and process by providing a physical barrier (18). Furthermore, encapsulation 
allows bacteria to be released in the intestinal environment and bypass the GIT altogether (19).  
The current main techniques for microencapsulation of probiotics are listed as the 
following: spray-drying, freeze-drying, emulsion, coacervation, and extrusion. When the active 
ingredient can be dissolved in the encapsulating agent which lead to emulsion or suspension, 
drying is used as an encapsulation method (20). Spray-drying is mainly used for probiotics 
production due to its ability for the large scale production (21). During spray drying, the 
atomization of solution which contains an active ingredient transports from drying chamber to 
the cyclone powder collector with heated air or gas stream. Finally, by a rapid evaporation of the 
solvent, the dried powder is collected in the collector (22). Spray-drying is considered the most 
economic and effective drying technique in probiotics industry. However, not only is spray-
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drying unsuccessful in promoting a high survival rate because of heating and drying, but also 
often fails to provide enough protection to the probiotics during storage (23). The process of 
spray-cooling is somewhat similar comparing to spray-drying. The main difference during the 
process is the carrier material and conditions of working. Spray-cooling is also not popular on 
probiotics encapsulation due to the thermal environment (24). 
Freeze-drying is one of the most widely used encapsulation technique for drying 
probiotics (25). The principle of dehydration process works by freezing the product and 
decreasing the pressure of the environment which can make the frozen water to sublimate from 
solid to gas (26). The water phase transition and avoided oxidation environment are one of the 
most important advantages of freeze-drying technique. However, most freeze dry techniques can 
only provide protection for the storage of probiotics, the freeze dried probiotics could be still 
vulnerable during digestion. Thus, the freeze-drying technique often needs to be combined with 
other encapsulating methods (27). 
Emulsion-based technique is considered to be an effective method that helps the 
microorganism cells to keep a high survival rate after passing the harsh conditions of the 
stomach (28). Coacervation process involves a precipitation of polymers by separating the phase. 
Coacervation is also a dehydration process which can turn the liquid phase to solid droplets to 
form encapsulation (29). Generally, the coacervation technique is used for flavor 
microencapsulation. Some probiotic bacteria are also rely on coacervation to provide protection 
by using water-in-oil emulsion as medium (30). 
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Extrusion are techniques that encapsulate probiotics in microspheres. The principle is to 
produce probiotics encapsulation with microspheres. Basically, the process can be separated to 2 
crucial steps: 1) the probiotics were dispersed to create small drops; 2) Gelatin or formation will 
turn the drops to solid by forming membrane in the surface of the drops (31). The size of the 
drops is determined by the size of nozzle and the speed of dropping. There have been many 
studies use extrusion techniques for probiotic encapsulation (32).         
Among the several encapsulated techniques, extrusion method shows the features that fit 
our objective the most. Not only because the process of extrusion technique is simple to operate, 
but also because the well protection it provides to the type of probiotic we are focusing on (33). 
The polymer formed during encapsulation should be food-grade, non-toxic, non-antimicrobial. 
Therefore, alginate and chitosan are considered to be two of the most widely used material for 
extrusion encapsulation (34). Chitosan-based extrusion can improve the survival rate of the 
probiotics during the process of GI tract and storage. However, due to the antibacterial activity of 
chitosan polymer, chitosan is mainly used as the surface shell in capsules (35). Alginate is  a 
popular material for coating which can cross-link CaCl2 solution. The process is simple, safe and 
cost (36). Furthermore, alginate-made capsule is biodegradable and biocompatible, which means 
alginate-based extrusion encapsulation is an effective way to delivery viable probiotics to the 
intestine (37).      
The Application of Probiotics 
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Many different probiotic bacteria have been successfully applied on several food industry 
areas in recent years (38). Bifidobacterium and Lactobacillus are the most widely used probiotics 
in varieties of food and dietary supplements. The commercial interest and market shares of 
probiotic foods are increasing in recent years (39). More and more new benefit strains were 
discovered and more and more new technology was using on probiotics application (40). 
Generally, probiotics were mostly used in fermented dairy food. Although there are some 
nondairy food products in the market, there is still lots of potential for nondairy food product 
development (41). In the future, probiotics food will definitely play an important role in human’s 
daily life.  
Objective 
    The objective of this study is to develop an encapsulation technique which can protect C. 
minuta and maintain its viability during storage and GI digestion. We also plan to develop 
specific C. Minuta-based functional food products. Our ultimate goal is to develop effective 
make C. minuta-based nutritional products that can help combat the global obesity and diabetes 
challenges.  
MATERIALS AND METHODS 
Culturing and Viability Test of Freeze Dried Powder 
    C. Minuta was bought from DSMZ (Leibniz Institute DSMZ, Germany). Routine culturing 
of this bacterium was in Reinforced Clostridial Medium (RCM Sparks, MD), using Hungate tube 
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method and under N2 gassing flowing (42). Then incubated at the temperature of 37°C for one 
night.   
    Freeze-drying technique was applied to get the bacteria powder with sucrose (New jersey, 
USA) as the washing buffer. Weigh optimized amount of freeze dried powder into RCM. After 
the solution was completely mixed, dilute the solution to several different concentrations with 
selected pipettes. Then pour-plating method was used to check the viability of the powder, and 
each diluted concentration was plated duplicated, All the plates were incubated at 37°C for one 
night and the CFU was calculated depended on the colonies checked at the next day.   
Microencapsulation 
    Alginate-based extrusion encapsulation technique was applied in the study. In order to 
encapsulate the bacteria with alginate cross-linking to form stable microbeads, optimized amount 
of freeze dried C. minuta powder and GOS were added into Sterile Sodium Alginate solution 
(New jersey, USA). Then a homogenizer (IKA, Germany) was used to mix the powder and the 
solution. Once the solution was completely mixed, a 10 mL syringe needle (30G, 1/2) was used 
to extrude the droplets into sterile CaCl2 (New jersey, USA) solution. The probiotic beads were 
left in CaCl2 solution for 30 minutes at room temperature after extrusion. Then all the beads were 
taken out from the solution and separated to two groups, one group were put into the dehydrator 
(Excalibur, USA) at room temperature. Once the beads were completely dried, these beads were 
transported into a centrifuge tube and store at room temperature for further viability test analysis 
and GIT. Another group of beads was used in double encapsulation. 
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Double Encapsulation 
    To improve the protection of encapsulation and prevent the probiotic b`eads from growing 
early before delivering, one group of alginate CaCl2 cross-linking beads from last step were put 
into sodium alginate solution again. After covering by sodium alginate solution, the beads were 
dipped into CaCl2 solution to form the second encapsulated layer. The double encapsulated beads 
were taken out from CaCl2 solution and put into the dehydrator at room temperature. Once the 
beads were completely dried, a centrifuge tube was used to store the beads at room temperature 
until viability test and GIT. 
Gastrointestinal Tract 
    The purpose of the encapsulation technique is to help C. minuta to achieve a high survival 
rate after GIT. Therefore, GIT is a crucial step of our study. The dried C. minuta beads were 
weighted before putting into a 2mL sterile centrifuge tube. HCl (Gibbstown, NJ) was loaded into 
a beaker, a pH meter and phosphate-buffered saline (PBS) was used to adjust the pH to reach 
pH=2 which closing to the environment of human stomach. Then the adjusted HCl and Pepsin 
(200mg/10mL, St louis, MO) were added into the tube. The tube was incubating at 37°C for 1 
hour. After incubating, the liquid was discarded. Enteric digestion formula solution 
(0.12g/10mL) was added into the tube to simulate intestine environment at 37°C for 1 hour. 
Single and double encapsulated C. minuta beads and freeze dried C. minuta powder were all  
gone through GIT tests following the same step during the study. 
Viability Test of the Beads after GIT 
 9 
 
The original dried C. minuta beads and the C. minuta beads after GIT were homogenized by 
a homogenizer. Then the solution was diluted to several different concentrations with sterile 
PBS. Pouring-plating technique was used to test the viability. During our study, the dilution 
factor is 10-7 to 10-1 which increased by 10-1 at each concentration. And each concentration is 
duplicated plated. All the plates were put into an incubator for overnight incubating at 37°C. The 
viability is valued by calculating the CFU which depends on the number of colonies counted at 
the next day.  
Extrusion Process Improvement 
    Although the process of extrusion worked well in the study, we still need to figure out a 
faster way to make large amount of beads. Three sterile tips were used to extrude the alginate 
solution instead of 10 mL syringe needle. A pump was used to extract the alginate solution via a 
silicon tube (Figure 1).    
Food Product Development 
    In order to develop microbeads on application, we decided to use jelly as the food vehicle to 
make coconut jelly with C. minuta beads. Gelatin (St louis, MO) solution was made and 
autoclaved at 121°C for 15 minutes and cool down to 40°C at room temperature. Then optimized 
amount of coconut water (Monrovia, CA) was added into gelatin solution as the main flavor of 
the jelly on a hot plate. The solution was put into a refrigerator for 30 minutes to solidify the 
solution at 4°C. Once the jelly is completely solidified, it was stored in a plastic plate at room 
temperature.  
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    Drinkable jelly is also considered as a good food product to carry microbeads. New formula 
C. minuta beads were made during this step. Optimized freeze dried C. minuta powder, coconut 
water and casein (New jersey, USA) were added into sterile sodium alginate solution (w/v) to 
make the extrusion solution. Then the new formula C. minuta beads were made by following the 
encapsulation pathway with a 10 mL syringe and a sterile tip (Figure 2). Glucomannan 
(Bloomingdale IL) and Kappa Corrageenan (York, ME) were added into demineralization (DI) 
water with the homogenizer to mix the solution. Then the solution was heated to 80°C and cool 
down at the room temperature. Once the temperature reached 40°C, the new formula C. minuta 
beads were put into the solution and put the solvent into a vacuum food-grade pack at a 4°C 
refrigerator for storage. 
Long Term Beads Stability Test 
    In order to figure out whether the probiotic beads are stable in room temperature for long 
period. Dried C. Minuta beads were put into 3 centrifuge tubes at room temperature for 8 weeks, 
the viability of the beads was checked every 4 weeks. The long term stability of C. Minuta beads 
in coconut jelly was also tested in a period of 2 weeks at room temperature.  
RESULTS AND DISCUSSION 
Encapsulation of C. Minuta Strain 
    The C. minuta freeze dried powder was encapsulated using an alginate-based extrusion 
technique, in order to protect C. minuta from being killed by the harsh conditions found in the 
GIT. The C. minuta beads are soft globoid balls which have the size of d=3mm (Figure 3). The 
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size of the dried beads was reduced a great deal, to d=1.6mm (Figure 4). The dried beads also 
became much harder than the original beads when dried. After arriving in the GIT, the dried 
beads absorbed water to expand and become soft again (Figure 5).  
Viability Test of Single and Double Encapsulated C. minuta Beads and Freeze Dried C. 
minuta Powder. 
    Pour-plate methods were applied during the viability test of C. minuta beads and powder. 
The viability of freeze dried C. minuta powder was 108.9 CFU/mg. From the results shown in the 
figure (Figure 6). we found that the viability of both single and double encapsulated beads were 
decreased, compared with that of the freeze dried powder. That was probably due to the 
influence of oxygen and higher temperature during the homogenization. Nevertheless, double 
encapsulated C. minuta beads presented a higher viability than single encapsulated beads, which 
is 107.95 CFU/mg to 107.72 CFU/mg. Thus, double encapsulation provides a more effective 
protection to reduce the viability lost during the process of encapsulation.  
Viability Test After Gastrointestinal Tract 
    The Gastrointestinal track (GIT) is considered as a way to check the for the effect of 
encapsulation. We set up the GIT experiment within three different groups: single encapsulated 
beads, double encapsulated beads, and freeze dried powder. Then the viability of the three 
groups’ subjects was tested by the pour-plate method (Figure 6). First, the viability of freeze 
dried powder dropped from 108.9 CFU/mg to 104.17 CFU/mg which indicates that freeze dried C. 
minuta powder cannot reach a high survival rate without any encapsulation. Second, either the 
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single encapsulated beads or the double encapsulated beads, displayed great protection to the 
viability of C. minuta after entrance to the GIT. Particularly, the viability of double encapsulated 
beads achieved a higher survival rate, 107.95 CFU/mg to 107.84 CFU/mg, than the single 
encapsulated beads did, 107.72 CFU/mg to 107.42 CFU/mg. Thus, we obtained the result that 
double encapsulated C. minuta beads had more effective protection during time spent in the GIT, 
than single encapsulated C. minuta beads. Overall, the C. minuta freeze dried powder needs to be 
encapsulated, if it is to safely go through the GIT without losing a lot viability. Alginate-based 
extrusion encapsulation method can successfully provide C. minuta enough protection to 
maintain the viability with a high survive-rate after time in the GIT. Double encapsulation of C. 
minuta beads presented a more effective protection than single encapsulation according to the 
viability test. However, that’s not the only reason why we chose double encapsulation as the 
main encapsulation method. Another necessary reason is to avoid the early growth of probiotics, 
before reaching the intestinal environment. Although the probiotics are covered by a shell during 
the encapsulation process, it still has contact with the external environment. Through the process 
of double encapsulation, the probiotics are definitely better protected and completely separated 
from the outer environment. So the double encapsulation was used as the main method to 
encapsulate the probiotics of the study.  
Long Term C. minuta Beads Stability Test 
    Although we had already figured out that alginate extrusion-based double encapsulation is 
very effective in protecting C. minuta probiotics, we still do not know the shelf-time of the 
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encapsulated C. minuta beads. And the shelf-time is considered to be an extremely important 
feature, which can determine the aspects of our further probiotic food product development. 
Hence, we designed an experiment of long term C. minuta beads stability test. The result was 
shown in Table 1. Then, we made a survival curve with the data collected in Table 1 (Figure 7). 
During the 8-week period of storage, the viability of double encapsulated beads was tested every 
4 weeks by the pour-plate method. According to the number of viability presented in Table 1 and 
the survival curve shown in Figure 7, the double encapsulated C. minuta beads can maintain the 
viability in the first 4 weeks almost perfectly, which was 108.0 CFU/mg, and the viability reduced 
a little bit from 108.0 CFU/mg to 107.6 CFU/mg in the next 4 weeks. The result indicated that the 
shelf-time of the double encapsulated C. minuta beads is at least 2 months, which provides a 
large potential for the future application of C. minuta beads related food products. 
C. minuta Beads Application: Coconut Jelly, Drinkable Jelly, and The Stability of C. 
minuta Beads in The Jelly    
Since the encapsulation technique provides good protection to C. minuta beads, we decided 
to develop some non-dairy food products with the probiotic beads. Coconut products were 
reported to have the ability to help humans to lose weight in recent studies (43). In addition, the 
gelatin-based jelly is also considered as a kind of healthy food, with having no sugar added (44). 
Therefore, coconut jelly was chosen as the food vehicle to carry C. minuta beads in the study 
(Figure 8). The stability of the beads in coconut jelly was tested by an experiment which lasted 
for 2 weeks. During the experiment, the viability of the beads in coconut jelly was tested every 2 
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days, started from the first day. The data was collected and is presented in Table 2. Then a 
survival curve was made in Figure 9. According to the data in the table, and the trend of the 
curve, it is easily claimed that the C. minuta beads are stable and the viability did not drop 
significantly. The aforementioned means that the C. minuta beads in coconut jelly have the 
ability to maintain their viability for at least two weeks at room temperature, which provides a 
huge potential for the application of C. minuta beads products.  
Drinkable jelly is a popular food in some Asian countries, such as China, Japan, and Korea. 
Therefore, we developed the coconut drinkable jelly by adding coconut water to both the alginate 
extrusion solution, and the drinkable jelly. The casein, which was added in the new formula 
beads, helps the beads to be suspended in the drinkable jelly (Figure10). 
    We chose to use the vacuum food-grade pack to store the drinkable jelly product, and also it 
was easy to drink by opening the side cap (Figure 11). Overall, the food product development of 
C. minuta beads were successful, and showed many possibilities for the probiotics food product 
industry. 
CONCLUSION 
Based on the results and analysis of our study, the double encapsulation of C. minuta 
successfully helped C. minuta to go through the GI tract within a high survival rate. However, 
the technique still needs to be improved upon to avoid the viability lost during the process of 
encapsulation. We have already tried some methods to reduce the viability lost, such as using ice 
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water to rapidly cool down the blender part of the homogenizer, in an effort to avoid the thermal 
condition.   
Particularly, the prebiotics added during encapsulation is a new idea for not only improving 
the survival rate during the process of passage through the gastrointestinal tract, but also 
improving the growth condition after the probiotics arrival in the intestinal environment. 
Currently, we have just finished study of the in-vitro effects of C. minuta encapsulation. The 
further in-vivo study is still in process of completion. Mice were selected as the object of animal 
study. The impact of adding prebiotics will be tested in future in-vivo studies. 
The application of probiotics has become more and more prevalent in recent years. There 
are also a lot of new probiotic foods and probiotic dietary supplements available in the 
supermarket, such as probiotic beverages, probiotic chocolates, and probiotic capsules. 
Bifidobacterium and Lactobacillus are still the most commonly used probiotics in food product 
application. However, the production of other, different, featured probiotics will change the 
situation sooner or later. 
Claimed from the results of the C. minuta beads stability test, the long shelf-time provides a 
lot of possibilities for developing related products. Moreover, The C. minuta beads-based 
coconut jelly, has great potential to become a successful probiotic food product. More flavors 
could also be applied during the product development, to fit more people’s preferences. The 
drinkable jelly also provides a more convenient and acceptable way to increase daily probiotic 
intake, than traditional probiotic supplements. 
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With the development of microbiology, more and more new probiotics will be discovered, 
and significantly more opportunities in preventing and treating certain kinds of diseases will be 
available. Encapsulation will keep playing a key role in protecting the probiotics, and delivering 
them to those whom imbibe them. 
Overall, we have already started our first step to make C. minuta available for obesity 
prevention and treatment. Future aspects of the study will focus on animal experimentation, and 
clinical trials of probiotic beads. Furthermore, other newly discovered bacteria can also be 
involved as the target encapsulation bacteria. Also, more products can be developed based on the 
probiotic beads. 
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Figure 1: Improved Extrusion process of encapsulation 
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Figure 2: New formula C. minuta beads extrusion 
 
 
 
 
 
 
 
 
 
 
 19 
 
 
Figure 3: Undried C. minuta beads 
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Figure 4: Dried double encapsulated C. Minuta beads 
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Figure 5: Double encapsulated beads after GIT  
 22 
 
 
Figure 6: viability test of C. minuta beads before and after GI tract: Comparison of single 
encapsulated beads (SB), double encapsulated beads (DB) viability, original bacteria powder 
(OP), single encapsulated beads after GIT (SBT), double encapsulated beads after GIT (DBT), 
and freeze dried powder after GIT (PT). 
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Figure 7: Long term double encapsulated C. minuta beads stability test 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
  
0
1
2
3
4
5
6
7
8
9
0 2 4 6 8 10
Lo
g
 C
FU
/m
g
Time (Week)
 24 
 
 
Figure 8: Coconut jelly with C. minuta beads 
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Figure 9: Survive curve of C. minuta beads in coconut jelly for 2 weeks  
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Figure 10: Casein and coconut water added probiotic beads 
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Figure 11: Drinkable coconut jelly with probiotic beads  
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Table 1: Long term double encapsulated C. minuta beads stability test at room temperature 
 
    Months                     viability log (CFU/mg) 
       
       0                              8.0 
       1                              8.0 
       2                              7.6  
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Table 2: Two-week stability of double encapsulated C. minuta beads in jelly 
 
     Days                     viability log (CFU/mg) 
      
      0                              8.7 
      1                              8.6 
      3                              8.6 
      5                              8.4 
      7                              8.4 
     14                              8.2 
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    Scientists tend to pay a lot attention to probiotics in recent years, due to its health related 
benefits for humans. Encapsulation is a necessary way to protect probiotics from being killed by 
harsh conditions of the gastrointestinal tract, and to help probiotics to release in the intestinal 
environment. This study is mainly focusing on the encapsulation technique of Christensenella 
minuta, and the food product development of C. minuta beads. The extrusion technique was 
applied as the encapsulation method, with alginate as the encapsulation material. The effect of 
single encapsulation and double encapsulation of C. minuta was compared to determine the 
layers of encapsulation. Long term stability experiments of double encapsulation C. minuta 
beads indicated that the beads formed by the extrusion technique is stable and maintains the 
viability, which was 107.95 CFU/mg to 107.84 CFU/mg. Gelatin jelly and drinkable jelly were 
developed as potential probiotic food products in the study. Animal experiments and clinical 
trials are still required to test the feature of C. minuta beads for future study. 
